Literature DB >> 30922942

Use of graded Semmes Weinstein monofilament testing for ascertaining peripheral neuropathy in people with and without diabetes.

Muideen T Olaiya1, Robert L Hanson2, Karen G Kavena2, Madhumita Sinha2, Dawn Clary3, Mark B Horton3, Robert G Nelson2, William C Knowler2.   

Abstract

AIMS: To assess peripheral neuropathy (PN) using graded Semmes Weinstein monofilaments (SWMs) and determine factors associated with PN among adult volunteers with and without diabetes.
METHODS: Adult volunteers were assessed for distal sensory PN using three graded SWMs. Four PN levels were defined: 0 (no PN; felt all three filaments), 1 (subclinical PN; insensate to 1-g filament), 2 (insensate to 10-g), or 3 (insensate to 75-g). Levels 2-3 were considered clinical PN. Associations with PN were determined using ordinal logistic regression.
RESULTS: In 1564 subjects (median age 41.9 years, 50.1% women), PN was subclinical or worse in 68.9% and clinical in 11.2%. Age-sex-race-adjusted prevalence of clinical PN was greater in people with diabetes (15.3%) than without (6.1%; P < 0.001). Associated factors included older age, male sex, greater BMI, greater heart rate, lower mean arterial pressure, and family history of diabetes or cardiovascular diseases. Higher PN levels associated with worse albuminuria and retinopathy. Only older age and male sex associated with PN both in people with and without diabetes.
CONCLUSIONS: PN is common in our sample, notably in those without diabetes, although diabetes greatly increases its risk. Using graded SWMs may have a prognostic value as it permits the identification of subclinical PN. Published by Elsevier B.V.

Entities:  

Keywords:  Diabetes; Diabetes complications; Peripheral neuropathy; Risk factors; Semmes Weinstein monofilament test

Mesh:

Year:  2019        PMID: 30922942      PMCID: PMC6544471          DOI: 10.1016/j.diabres.2019.03.029

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  28 in total

Review 1.  The prevalence, predictors, and consequences of peripheral sensory neuropathy in older patients.

Authors:  James W Mold; Sara K Vesely; Barbara A Keyl; Joan B Schenk; Michelle Roberts
Journal:  J Am Board Fam Pract       Date:  2004 Sep-Oct

2.  Semmes-Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration.

Authors:  S Kumar; D J Fernando; A Veves; E A Knowles; M J Young; A J Boulton
Journal:  Diabetes Res Clin Pract       Date:  1991-08       Impact factor: 5.602

Review 3.  The Semmes Weinstein monofilament examination as a screening tool for diabetic peripheral neuropathy.

Authors:  Yuzhe Feng; Felix J Schlösser; Bauer E Sumpio
Journal:  J Vasc Surg       Date:  2009-07-30       Impact factor: 4.268

4.  Simple screening tests for peripheral neuropathy in the diabetes clinic.

Authors:  B A Perkins; D Olaleye; B Zinman; V Bril
Journal:  Diabetes Care       Date:  2001-02       Impact factor: 19.112

5.  Vascular risk factors and diabetic neuropathy.

Authors:  Solomon Tesfaye; Nish Chaturvedi; Simon E M Eaton; John D Ward; Christos Manes; Constantin Ionescu-Tirgoviste; Daniel R Witte; John H Fuller
Journal:  N Engl J Med       Date:  2005-01-27       Impact factor: 91.245

6.  Epidemiology of distal symmetrical neuropathies in the Italian elderly.

Authors:  M Baldereschi; M Inzitari; A Di Carlo; G Farchi; E Scafato; D Inzitari
Journal:  Neurology       Date:  2007-05-01       Impact factor: 9.910

Review 7.  Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales.

Authors:  C P Wilkinson; Frederick L Ferris; Ronald E Klein; Paul P Lee; Carl David Agardh; Matthew Davis; Diana Dills; Anselm Kampik; R Pararajasegaram; Juan T Verdaguer
Journal:  Ophthalmology       Date:  2003-09       Impact factor: 12.079

8.  Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3.

Authors:  Dan Ziegler; Wolfgang Rathmann; Thorsten Dickhaus; Christa Meisinger; Andreas Mielck
Journal:  Diabetes Care       Date:  2007-11-26       Impact factor: 19.112

9.  Prevalence and risk factors for neuropathy in a Canadian First Nation community.

Authors:  Sharon G Bruce; T Kue Young
Journal:  Diabetes Care       Date:  2008-05-28       Impact factor: 19.112

10.  Association between diabetic nephropathy and other diabetic microvascular and macrovascular complications.

Authors:  Anila Chandy; Basant Pawar; Mary John; Rajesh Isaac
Journal:  Saudi J Kidney Dis Transpl       Date:  2008-11
View more
  4 in total

1.  Characterization of Exome Variants and Their Metabolic Impact in 6,716 American Indians from the Southwest US.

Authors:  Hye In Kim; Bin Ye; Nehal Gosalia; Çiğdem Köroğlu; Robert L Hanson; Wen-Chi Hsueh; William C Knowler; Leslie J Baier; Clifton Bogardus; Alan R Shuldiner; Cristopher V Van Hout
Journal:  Am J Hum Genet       Date:  2020-07-07       Impact factor: 11.025

2.  Assessment of the potential role of natural selection in type 2 diabetes and related traits across human continental ancestry groups: comparison of phenotypic with genotypic divergence.

Authors:  Robert L Hanson; Cristopher V Van Hout; Wen-Chi Hsueh; Alan R Shuldiner; Sayuko Kobes; Madhumita Sinha; Leslie J Baier; William C Knowler
Journal:  Diabetologia       Date:  2020-09-04       Impact factor: 10.122

3.  Exome Sequencing of 21 Bardet-Biedl Syndrome (BBS) Genes to Identify Obesity Variants in 6,851 American Indians.

Authors:  Samantha E Day; Yunhua L Muller; Cigdem Koroglu; Sayuko Kobes; Kim Wiedrich; Darin Mahkee; Hye In Kim; Cris Van Hout; Nehal Gosalia; Bin Ye; Alan R Shuldiner; William C Knowler; Robert L Hanson; Clifton Bogardus; Leslie J Baier
Journal:  Obesity (Silver Spring)       Date:  2021-02-22       Impact factor: 5.002

4.  Prevalence of peripheral neuropathy defined by monofilament insensitivity in middle-aged and older adults in two US cohorts.

Authors:  Caitlin W Hicks; Dan Wang; B Gwen Windham; Kunihiro Matsushita; Elizabeth Selvin
Journal:  Sci Rep       Date:  2021-09-27       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.